"Sentara Heart Hospital is recognized as a destination medical center nationally recognized for offering quality comprehensive heart care from advance diagnostics and imaging to minimally invasive heart procedures, heart surgery and heart transplants. On the campus of Sentara Norfolk General Hospital, the hospital consistently ranks among the nation's top heart programs in U.S. News & World Report . In the 2016-17 rankings, the cardiology and heart surgery program ranked 24th in the country, which marks the program's 17th year among the nation's elite top 50 hospitals in the survey."

During the past decade, Sentara Heart Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sentara Heart Hospital" #1 sponsor was "Bolton Medical" with 5 trials, followed by "Merit Medical Systems, Inc." with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Biosense Webster, Inc." with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sentara Heart Hospital" #1 collaborator was "Bolton Medical" with 1 trials as a collaborator, "CryoLife, Inc." with 1 trials as a collaborator, "Eastern Virginia Medical School" with 1 trials as a collaborator, "Ethicon Endo-Surgery" with 1 trials as a collaborator and "Integra Clinical Trial Solutions - statistical analysis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Sentara Heart Hospital" are "Abdominal Aortic Aneurysm" (2 trials), "Thoracic Aortic Aneurysm" (2 trials), "ABDOMINAL AORTIC ANEURYSMS" (1 trials), "Abdominal Aortic Aneurysms" (1 trials) and "Aortic Dissection Type B" (1 trials). Many other conditions were trialed in "Sentara Heart Hospital" in a lesser frequency.

Most popular intervention types in "Sentara Heart Hospital" are "Device" (14 trials), "Procedure" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "HeRO Vascular Access Device" (2 trials), "Relay Thoracic Stent-Graft" (2 trials), "Abdominal" (1 trials), "AneuRx AAA stent graft / Talent AAA stent graft" (1 trials) and "Biocor and Biocor Supra valves" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sentara Heart Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Sentara Heart Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sentara Heart Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sentara Heart Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".